Condition: Cancer · Myeloid Neoplasm · Sponsor: University of Rochester
This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.
This description comes directly from the study's public registry record.
Kah Poh Loh · 585-275-5863 · kahpoh_loh@urmc.rochester.edu
Becky Gravenstede · 585-727-4728 · becky_gravenstede@urmc.rochester.edu
Always discuss trial participation with your own doctor first.
| University of Rochester Medical Center/Wilmot Cancer Institute | Rochester, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04981821